Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.
about
Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effects of nateglinide and ros ...... ized crossover clinical study.
@ast
Effects of nateglinide and ros ...... ized crossover clinical study.
@en
type
label
Effects of nateglinide and ros ...... ized crossover clinical study.
@ast
Effects of nateglinide and ros ...... ized crossover clinical study.
@en
prefLabel
Effects of nateglinide and ros ...... ized crossover clinical study.
@ast
Effects of nateglinide and ros ...... ized crossover clinical study.
@en
P2093
P2860
P1476
Effects of nateglinide and ros ...... mized crossover clinical study
@en
P2093
Dalva Marreiro Rocha
Maria Elizabeth Rossi da Silva
Maria Rosário Cunha
Márcia Regina Silva Correia
Rosa Ferreira Dos Santos
Rosa Tsumeshiro Fukui
P2860
P2888
P356
10.1186/S13098-015-0120-6
P577
2016-01-04T00:00:00Z
P5875
P6179
1041775265